SG10201505619QA - Scheme for administering n-hydroxy-4-{2-[3-(n,n-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}benzamide - Google Patents
Scheme for administering n-hydroxy-4-{2-[3-(n,n-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}benzamideInfo
- Publication number
- SG10201505619QA SG10201505619QA SG10201505619QA SG10201505619QA SG10201505619QA SG 10201505619Q A SG10201505619Q A SG 10201505619QA SG 10201505619Q A SG10201505619Q A SG 10201505619QA SG 10201505619Q A SG10201505619Q A SG 10201505619QA SG 10201505619Q A SG10201505619Q A SG 10201505619QA
- Authority
- SG
- Singapore
- Prior art keywords
- ylcarbonylamino
- dimethylaminomethyl
- benzofuran
- benzamide
- ethoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161573585P | 2011-09-08 | 2011-09-08 | |
| FR1102727 | 2011-09-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201505619QA true SG10201505619QA (en) | 2015-08-28 |
Family
ID=47830027
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201400120UA SG11201400120UA (en) | 2011-09-08 | 2012-09-07 | Scheme for administering n-hydroxy-4-{2-[3-(n,n-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}benzamide |
| SG10201505619QA SG10201505619QA (en) | 2011-09-08 | 2012-09-07 | Scheme for administering n-hydroxy-4-{2-[3-(n,n-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}benzamide |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201400120UA SG11201400120UA (en) | 2011-09-08 | 2012-09-07 | Scheme for administering n-hydroxy-4-{2-[3-(n,n-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}benzamide |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8883199B2 (es) |
| EP (1) | EP2753322B1 (es) |
| JP (1) | JP6014142B2 (es) |
| KR (1) | KR20140073521A (es) |
| CN (1) | CN103889409A (es) |
| AR (1) | AR087803A1 (es) |
| AU (2) | AU2012306122A1 (es) |
| CA (1) | CA2847011A1 (es) |
| HK (1) | HK1201150A1 (es) |
| MX (1) | MX2014002663A (es) |
| RU (1) | RU2600793C2 (es) |
| SG (2) | SG11201400120UA (es) |
| TW (1) | TWI544920B (es) |
| UA (1) | UA113634C2 (es) |
| UY (1) | UY34295A (es) |
| WO (1) | WO2013034863A1 (es) |
| ZA (1) | ZA201401710B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004092115A2 (en) | 2003-04-07 | 2004-10-28 | Axys Pharmaceuticals Inc. | Hydroxamates as therapeutic agents |
| DK2099442T3 (en) * | 2006-12-26 | 2015-02-16 | Pharmacyclics Inc | Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
| NZ579048A (en) * | 2007-01-30 | 2012-05-25 | Pharmacyclics Inc | Methods for determining cancer resistance to histone deacetylase inhibitors |
| US8603521B2 (en) | 2009-04-17 | 2013-12-10 | Pharmacyclics, Inc. | Formulations of histone deacetylase inhibitor and uses thereof |
| US9492423B2 (en) | 2011-09-13 | 2016-11-15 | Pharmacyclics Llc | Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof |
| EP3027192A4 (en) | 2013-08-02 | 2017-03-22 | Pharmacyclics, LLC | Methods for the treatment of solid tumors |
| KR101684854B1 (ko) * | 2016-06-13 | 2016-12-09 | 아이오틴 주식회사 | 보호자 알림기능을 이용한 휴대용 스마트약통 및 이를 포함하는 복용시간 알림시스템 |
| CN114146181B (zh) * | 2021-10-29 | 2022-09-09 | 徐诺药业(南京)有限公司 | 含Pan-HDAC和免疫检查点抑制剂的组合及应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1489078E (pt) * | 2002-03-28 | 2010-02-24 | Mitsubishi Tanabe Pharma Corp | Derivados de benzofurano |
| CN100566711C (zh) * | 2002-04-15 | 2009-12-09 | 斯隆-凯特林癌症研究院 | 治疗癌症的化合物及其用途 |
| WO2004092115A2 (en) * | 2003-04-07 | 2004-10-28 | Axys Pharmaceuticals Inc. | Hydroxamates as therapeutic agents |
| EP1874324A1 (en) * | 2005-04-21 | 2008-01-09 | Alza Corporation | Method for treating advanced ovarian cancer with doxorubicin entrapped in liposomes |
-
2012
- 2012-08-28 UY UY0001034295A patent/UY34295A/es not_active Application Discontinuation
- 2012-09-06 US US13/605,116 patent/US8883199B2/en active Active
- 2012-09-06 TW TW101132604A patent/TWI544920B/zh not_active IP Right Cessation
- 2012-09-07 WO PCT/FR2012/052004 patent/WO2013034863A1/fr active Application Filing
- 2012-09-07 KR KR1020147009191A patent/KR20140073521A/ko active Search and Examination
- 2012-09-07 JP JP2014529056A patent/JP6014142B2/ja active Active
- 2012-09-07 SG SG11201400120UA patent/SG11201400120UA/en unknown
- 2012-09-07 CA CA2847011A patent/CA2847011A1/fr not_active Abandoned
- 2012-09-07 SG SG10201505619QA patent/SG10201505619QA/en unknown
- 2012-09-07 EP EP12769146.7A patent/EP2753322B1/fr active Active
- 2012-09-07 AR ARP120103299A patent/AR087803A1/es unknown
- 2012-09-07 AU AU2012306122A patent/AU2012306122A1/en not_active Abandoned
- 2012-09-07 RU RU2014113399/15A patent/RU2600793C2/ru not_active IP Right Cessation
- 2012-09-07 MX MX2014002663A patent/MX2014002663A/es unknown
- 2012-09-07 CN CN201280041854.3A patent/CN103889409A/zh active Pending
- 2012-09-07 UA UAA201403500A patent/UA113634C2/uk unknown
-
2014
- 2014-03-07 ZA ZA2014/01710A patent/ZA201401710B/en unknown
- 2014-10-09 US US14/510,369 patent/US20150024040A1/en not_active Abandoned
- 2014-12-23 HK HK14112851.7A patent/HK1201150A1/xx unknown
-
2016
- 2016-04-22 AU AU2016202594A patent/AU2016202594B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014526457A (ja) | 2014-10-06 |
| US20150024040A1 (en) | 2015-01-22 |
| US8883199B2 (en) | 2014-11-11 |
| AU2016202594B2 (en) | 2017-09-14 |
| US20130064880A1 (en) | 2013-03-14 |
| TWI544920B (zh) | 2016-08-11 |
| AR087803A1 (es) | 2014-04-16 |
| AU2016202594A1 (en) | 2016-05-19 |
| UA113634C2 (uk) | 2017-02-27 |
| SG11201400120UA (en) | 2014-09-26 |
| JP6014142B2 (ja) | 2016-10-25 |
| WO2013034863A1 (fr) | 2013-03-14 |
| CN103889409A (zh) | 2014-06-25 |
| CA2847011A1 (fr) | 2013-03-14 |
| NZ622112A (en) | 2016-07-29 |
| RU2600793C2 (ru) | 2016-10-27 |
| EP2753322A1 (fr) | 2014-07-16 |
| AU2012306122A1 (en) | 2014-03-13 |
| TW201313228A (zh) | 2013-04-01 |
| UY34295A (es) | 2013-04-30 |
| EP2753322B1 (fr) | 2016-08-03 |
| MX2014002663A (es) | 2014-08-29 |
| HK1201150A1 (en) | 2015-08-28 |
| KR20140073521A (ko) | 2014-06-16 |
| RU2014113399A (ru) | 2015-10-20 |
| ZA201401710B (en) | 2015-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201505619QA (en) | Scheme for administering n-hydroxy-4-{2-[3-(n,n-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}benzamide | |
| IL242279A0 (en) | Compounds of 3-chloro-3]-n-(pyrimidine-2-ylamino)phenyl]substituted propanamide and their salts | |
| HK1178387A1 (zh) | 種凝膠、含它的耐溫型軟糖及其製備方法 | |
| AP3589A (en) | A novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes | |
| EP2679592A4 (en) | NEW HETEROCYCLIC COMPOUND, PROCESS FOR PRODUCING INTERMEDIATE PRODUCTS THEREOF AND USE THEREOF | |
| PT2734499T (pt) | Derivados de merocianina | |
| EP2699091A4 (en) | 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS | |
| HK1198535A1 (en) | 5-(3-aminophenyl)-5-alkyl-5,6-dihydro-2h-[1,4] oxazin-3-amine derivatives 5-(3-)-5--5,6--2h-[1,4]-3- | |
| CO6870039A2 (es) | 3-(bifenil-3-il)-4-hidroxi-8-metoxi-1-azaespiro[4.5]dec-3-en-2-onas sustituidas | |
| HK1201060A1 (zh) | -二甲基苯基 -丙醛的製備方法 | |
| BR112013019524A2 (pt) | método para a produção de 2,3-butanodiol por fermentação | |
| BR112013019525A2 (pt) | método para a produção de 2,3-butanodiol por fermentação | |
| FI20116030A (fi) | Menetelmä RF-suotimen valmistamiseksi ja RF-suodin | |
| BR112012025490A2 (pt) | ''método para produção de 1,5 oebtanodiamina'' | |
| HK1190706A1 (en) | Sec-hydroxycyclohexyl derivatives as hsl inhibitors for the treatment diabetes hsl - | |
| BR112013018973A2 (pt) | processo para a preparação de derivados de 1-h-pirrolidina-2,4-diona | |
| EP2734499A4 (en) | MEROCYANINE DERIVATIVES | |
| TH1401006705A (th) | วิธีการสำหรับการเตรียม 2-(2,3-ไดเมททิลฟีนิล)-1-โพรพานัล (2-(2,3-dimethylphenyl)-1-propanal) | |
| DK2695103T3 (da) | Scoringsfunktion for bindingsaffinitet, der indbefatter en straftildelingsbetingelse | |
| DK2785675T3 (da) | 5,5-dimethyl-2-propyl-hexahydro-2,4a-methanonaphthalen-1-on som duftmiddel | |
| PL392868A1 (pl) | 2-Metoksyoctany, 2-(2-metoksyetoksy)octany i 2-[2-(2-metoksyetoksy)etoksy]octany cykloheksyloamoniowe oraz sposób ich otrzymywania | |
| TH118939B (th) | กรรมวิธีที่ปรับปรุงให้ดีขึ้นแล้วสำหรับการเตรียมอนุพันธ์แทกเซน | |
| PL396024A1 (pl) | Sposób wytwarzania 4,2',4' -trihydroksy-6'-metoksy-3'-prenylo-α,ß-dihydrochalkonu | |
| DK2461074T3 (da) | Drivtandkrans til maskiner | |
| PL390882A1 (pl) | Kompozycja, zwłaszcza do wytwarzania stabilnej emulsji naturalnego bursztynu |